{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T13:29:01Z","timestamp":1792848541636,"version":"4.5.0"},"reference-count":67,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,4,9]],"date-time":"2025-04-09T00:00:00Z","timestamp":1744156800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,4,9]],"date-time":"2025-04-09T00:00:00Z","timestamp":1744156800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100000065","name":"U.S. Department of Health & Human Services | NIH | National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["RF1NS095799"],"award-info":[{"award-number":["RF1NS095799"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"DOI":"10.1038\/s41467-025-58496-w","type":"journal-article","created":{"date-parts":[[2025,4,8]],"date-time":"2025-04-08T21:58:18Z","timestamp":1744149498000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Tip60 HAT activators as therapeutic modulators for Alzheimer\u2019s disease"],"prefix":"10.1038","volume":"16","author":[{"given":"Akanksha","family":"Bhatnagar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina M.","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gu Gu","family":"Nge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aprem","family":"Zaya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rohan","family":"Dasari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neha","family":"Chongtham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bijaya","family":"Manandhar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3532-8669","authenticated-orcid":false,"given":"Sandhya","family":"Kortagere","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9709-3690","authenticated-orcid":false,"given":"Felice","family":"Elefant","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,9]]},"reference":[{"key":"58496_CR1","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.nlm.2011.04.002","volume":"96","author":"RM Stilling","year":"2011","unstructured":"Stilling, R. M. & Fischer, A. The role of histone acetylation in age-associated memory impairment and Alzheimer\u2019s disease. Neurobiol. Learn. Mem. 96, 19\u201326 (2011).","journal-title":"Neurobiol. Learn. Mem."},{"key":"58496_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12877-016-0342-y","volume":"16","author":"LO Killin","year":"2016","unstructured":"Killin, L. O., Starr, J. M., Shiue, I. J. & Russ, T. C. Environmental risk factors for dementia: a systematic review. BMC Geriatrics 16, 1\u201328 (2016).","journal-title":"BMC Geriatrics"},{"key":"58496_CR3","volume":"2011","author":"A Peserico","year":"2011","unstructured":"Peserico, A. & Simone, C. Physical and functional HAT\/HDAC interplay regulates protein acetylation balance. J. Biomed. Biotechnol. 2011, 371832 (2011).","journal-title":"J. Biomed. Biotechnol."},{"key":"58496_CR4","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1016\/j.tins.2018.05.005","volume":"41","author":"A Berson","year":"2018","unstructured":"Berson, A., Nativio, R., Berger, S. L. & Bonini, N. M. Epigenetic regulation in neurodegenerative diseases. Trends Neurosci. 41, 587\u2013598 (2018).","journal-title":"Trends Neurosci."},{"key":"58496_CR5","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1038\/sj.cdd.4401769","volume":"13","author":"R Saha","year":"2006","unstructured":"Saha, R. & Pahan, K. HATs and HDACs in neurodegeneration: a tale of disconcerted acetylation homeostasis. Cell Death Differ. 13, 539 (2006).","journal-title":"Cell Death Differ."},{"key":"58496_CR6","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1038\/nature10849","volume":"483","author":"J Gr\u00e4ff","year":"2012","unstructured":"Gr\u00e4ff, J. et al. An epigenetic blockade of cognitive functions in the neurodegenerating brain. Nature 483, 222 (2012).","journal-title":"Nature"},{"key":"58496_CR7","doi-asserted-by":"publisher","first-page":"226","DOI":"10.3389\/fncel.2015.00226","volume":"9","author":"X Lu","year":"2015","unstructured":"Lu, X., Wang, L., Yu, C., Yu, D. & Yu, G. Histone acetylation modifiers in the pathogenesis of Alzheimer\u2019s disease. Front. Cell. Neurosci. 9, 226\u2013226 (2015).","journal-title":"Front. Cell. Neurosci."},{"key":"58496_CR8","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1038\/npp.2012.86","volume":"38","author":"L Peixoto","year":"2013","unstructured":"Peixoto, L. & Abel, T. The role of histone acetylation in memory formation and cognitive impairments. Neuropsychopharmacology 38, 62\u201376 (2013).","journal-title":"Neuropsychopharmacology"},{"key":"58496_CR9","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1016\/j.bbagrm.2010.08.012","volume":"1799","author":"BR Selvi","year":"2010","unstructured":"Selvi, B. R., Cassel, J.-C., Kundu, T. K. & Boutillier, A.-L. Tuning acetylation levels with HAT activators: therapeutic strategy in neurodegenerative diseases. Biochim. et. Biophys. Acta (BBA)-Gene Regul. Mechan. 1799, 840\u2013853 (2010).","journal-title":"Biochim. et. Biophys. Acta (BBA)-Gene Regul. Mechan."},{"key":"58496_CR10","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1007\/s13311-013-0204-7","volume":"10","author":"A Schneider","year":"2013","unstructured":"Schneider, A. et al. Acetyltransferases (HATs) as targets for neurological therapeutics. Neurotherapeutics 10, 568\u2013588 (2013).","journal-title":"Neurotherapeutics"},{"key":"58496_CR11","doi-asserted-by":"publisher","first-page":"4527","DOI":"10.1021\/jp067655s","volume":"111","author":"K Mantelingu","year":"2007","unstructured":"Mantelingu, K. et al. Activation of p300 histone acetyltransferase by small molecules altering enzyme structure:\u2009 probed by surface-enhanced Raman spectroscopy. J. Phys. Chem. B 111, 4527\u20134534 (2007).","journal-title":"J. Phys. Chem. B"},{"key":"58496_CR12","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1002\/acn3.147","volume":"2","author":"A Didonna","year":"2015","unstructured":"Didonna, A. & Opal, P. The promise and perils of HDAC inhibitors in neurodegeneration. Ann. Clin. Transl. Neurol. 2, 79\u2013101 (2015).","journal-title":"Ann. Clin. Transl. Neurol."},{"key":"58496_CR13","doi-asserted-by":"publisher","first-page":"6537","DOI":"10.1093\/emboj\/cdg615","volume":"22","author":"C Rouaux","year":"2003","unstructured":"Rouaux, C. et al. Critical loss of CBP\/p300 histone acetylase activity by caspase\u20106 during neurodegeneration. EMBO J. 22, 6537\u20136549 (2003).","journal-title":"EMBO J."},{"key":"58496_CR14","doi-asserted-by":"publisher","first-page":"5051","DOI":"10.2174\/13816128113199990382","volume":"19","author":"LM Valor","year":"2013","unstructured":"Valor, L. M. et al. Lysine acetyltransferases CBP and p300 as therapeutic targets in cognitive and neurodegenerative disorders. Curr. Pharm. Des. 19, 5051\u20135064 (2013).","journal-title":"Curr. Pharm. Des."},{"key":"58496_CR15","doi-asserted-by":"publisher","first-page":"30","DOI":"10.3389\/fncel.2013.00030","volume":"7","author":"SK Pirooznia","year":"2013","unstructured":"Pirooznia, S. K. & Elefant, F. Targeting specific HATs for neurodegenerative disease treatment: translating basic biology to therapeutic possibilities. Front. Cell. Neurosci. 7, 30 (2013).","journal-title":"Front. Cell. Neurosci."},{"key":"58496_CR16","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1080\/09168451.2014.993914","volume":"79","author":"C-H Kim","year":"2015","unstructured":"Kim, C.-H. et al. The chromodomain-containing histone acetyltransferase TIP60 acts as a code reader, recognizing the epigenetic codes for initiating transcription. Biosci., Biotechnol. Biochem. 79, 532\u2013538 (2015).","journal-title":"Biosci., Biotechnol. Biochem."},{"key":"58496_CR17","doi-asserted-by":"publisher","first-page":"1571","DOI":"10.1534\/genetics.114.171660","volume":"198","author":"S Xu","year":"2014","unstructured":"Xu, S. et al. Epigenetic control of learning and memory in Drosophila by Tip60 HAT action. Genetics 198, 1571\u20131586 (2014).","journal-title":"Genetics"},{"key":"58496_CR18","doi-asserted-by":"publisher","first-page":"4569","DOI":"10.1523\/JNEUROSCI.2840-17.2018","volume":"38","author":"P Panikker","year":"2018","unstructured":"Panikker, P. et al. Restoring Tip60 HAT\/HDAC2 balance in the neurodegenerative brain relieves epigenetic transcriptional repression and reinstates cognition. J. Neurosci. 38, 4569\u20134583 (2018).","journal-title":"J. Neurosci."},{"key":"58496_CR19","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1080\/15592294.2021.1959742","volume":"17","author":"M Beaver","year":"2022","unstructured":"Beaver, M. et al. Chromatin and transcriptomic profiling uncover dysregulation of the Tip60 HAT\/HDAC2 epigenomic landscape in the neurodegenerative brain. Epigenetics 17, 786\u2013807 (2022).","journal-title":"Epigenetics"},{"key":"58496_CR20","doi-asserted-by":"publisher","first-page":"7535","DOI":"10.1523\/JNEUROSCI.3739-12.2013","volume":"33","author":"AA Johnson","year":"2013","unstructured":"Johnson, A. A., Sarthi, J., Pirooznia, S. K., Reube, W. & Elefant, F. Increasing Tip60 HAT levels rescues axonal transport defects and associated behavioral phenotypes in a Drosophila Alzheimer\u2019s disease model. J. Neurosci. 33, 7535\u20137547 (2013).","journal-title":"J. Neurosci."},{"key":"58496_CR21","doi-asserted-by":"publisher","first-page":"e18412","DOI":"10.1371\/journal.pone.0018412","volume":"6","author":"M Lorbeck","year":"2011","unstructured":"Lorbeck, M., Pirooznia, K., Sarthi, J., Zhu, X. & Elefant, F. Microarray analysis uncovers a role for Tip60 in nervous system function and general metabolism. PLoS ONE 6, e18412 (2011).","journal-title":"PLoS ONE"},{"key":"58496_CR22","doi-asserted-by":"publisher","first-page":"e41776","DOI":"10.1371\/journal.pone.0041776","volume":"7","author":"SK Pirooznia","year":"2012","unstructured":"Pirooznia, S. K. et al. Tip60 HAT activity mediates APP induced lethality and apoptotic cell death in the CNS of a Drosophila Alzheimer\u2019s disease model. PLoS ONE 7, e41776 (2012).","journal-title":"PLoS ONE"},{"key":"58496_CR23","doi-asserted-by":"publisher","first-page":"e26202","DOI":"10.1371\/journal.pone.0026202","volume":"6","author":"J Sarthi","year":"2011","unstructured":"Sarthi, J. & Elefant, F. dTip60 HAT activity controls synaptic bouton expansion at the Drosophila neuromuscular junction. PLoS ONE 6, e26202 (2011).","journal-title":"PLoS ONE"},{"key":"58496_CR24","doi-asserted-by":"publisher","first-page":"e0159623","DOI":"10.1371\/journal.pone.0159623","volume":"11","author":"S Xu","year":"2016","unstructured":"Xu, S., Panikker, P., Iqbal, S. & Elefant, F. Tip60 HAT action mediates environmental enrichment induced cognitive restoration. PLoS ONE 11, e0159623 (2016).","journal-title":"PLoS ONE"},{"key":"58496_CR25","doi-asserted-by":"crossref","unstructured":"Zhu, X., Singh, N., Donnelly, C., Boimel, P. & Elefant, F. The cloning and characterization of the histone acetyltransferase human homolog Dmel\\TIP60 in Drosophila melanogaster: Dmel\\TIP60 is essential for multicellular development. Genetics 175, 1229\u20131240 (2007).","DOI":"10.1534\/genetics.106.063685"},{"key":"58496_CR26","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-75035-3","volume":"10","author":"M Beaver","year":"2020","unstructured":"Beaver, M. et al. Disruption of Tip60 HAT mediated neural histone acetylation homeostasis is an early common event in neurodegenerative diseases. Sci. Rep. 10, 18265 (2020).","journal-title":"Sci. Rep."},{"key":"58496_CR27","first-page":"789","volume":"12","author":"S Kortagere","year":"2006","unstructured":"Kortagere, S. & Welsh, W. J. Development and application of hybrid structure based method for efficient screening of ligands binding to G-protein coupled receptors. J. Compout. Aided Mol. Des. 12, 789\u2013802 (2006).","journal-title":"J. Compout. Aided Mol. Des."},{"key":"58496_CR28","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1006\/jmbi.1996.0897","volume":"267","author":"G Jones","year":"1997","unstructured":"Jones, G., Willett, P., Glen, R. C., Leach, A. R. & Taylor, R. Development and validation of a genetic algorithm for flexible docking. J. Mol. Biol. 267, 727\u2013748 (1997).","journal-title":"J. Mol. Biol."},{"key":"58496_CR29","doi-asserted-by":"publisher","first-page":"1229","DOI":"10.1016\/S0196-9781(99)00127-8","volume":"20","author":"C Gentry","year":"1999","unstructured":"Gentry, C. et al. The effect of halogenation on blood\u2013brain barrier permeability of a novel peptide drug\u2606. Peptides 20, 1229\u20131238 (1999).","journal-title":"Peptides"},{"key":"58496_CR30","doi-asserted-by":"publisher","first-page":"664","DOI":"10.2174\/1573406413666170209124302","volume":"13","author":"JA Castillo-Garit","year":"2017","unstructured":"Castillo-Garit, J. A., Casanola-Martin, G. M., Le-Thi-Thu, H., Pham-The, H. & Barigye, S. J. A simple method to predict blood-brain barrier permeability of drug-like compounds using classification trees. Med Chem. 13, 664\u2013669 (2017).","journal-title":"Med Chem."},{"key":"58496_CR31","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1021\/ed100186y","volume":"87","author":"Y Tang","year":"2010","unstructured":"Tang, Y., Zeng, X. & Liang, J. Surface plasmon resonance: an introduction to a surface spectroscopy technique. J. Chem. Educ. 87, 742\u2013746 (2010).","journal-title":"J. Chem. Educ."},{"key":"58496_CR32","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1038\/s41586-018-0387-5","volume":"560","author":"JB Baell","year":"2018","unstructured":"Baell, J. B. et al. Inhibitors of histone acetyltransferases KAT6A\/B induce senescence and arrest tumour growth. Nature 560, 253\u2013257 (2018).","journal-title":"Nature"},{"key":"58496_CR33","doi-asserted-by":"publisher","DOI":"10.1002\/wdev.346","volume":"8","author":"TT Su","year":"2019","unstructured":"Su, T. T. Drug screening in Drosophila; why, when, and when not? Wiley Interdiscip. Rev. Dev. Biol. 8, e346 (2019).","journal-title":"Wiley Interdiscip. Rev. Dev. Biol."},{"key":"58496_CR34","doi-asserted-by":"publisher","DOI":"10.1038\/srep02120","volume":"3","author":"G Gasque","year":"2013","unstructured":"Gasque, G., Conway, S., Huang, J., Rao, Y. & Vosshall, L. B. Small molecule drug screening in Drosophila identifies the 5HT2A receptor as a feeding modulation target. Sci. Rep. 3, srep02120 (2013).","journal-title":"Sci. Rep."},{"key":"58496_CR35","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1111\/jnc.12446","volume":"127","author":"S Lenz","year":"2013","unstructured":"Lenz, S., Karsten, P., Schulz, J. B. & Voigt, A. Drosophila as a screening tool to study human neurodegenerative diseases. J. Neurochem. 127, 453\u2013460 (2013).","journal-title":"J. Neurochem."},{"key":"58496_CR36","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1242\/dev.118.2.401","volume":"118","author":"AH Brand","year":"1993","unstructured":"Brand, A. H. & Perrimon, N. Targeted gene expression as a means of altering cell fates and generating dominant phenotypes. Development 118, 401\u2013415 (1993).","journal-title":"Development"},{"key":"58496_CR37","doi-asserted-by":"publisher","first-page":"2324","DOI":"10.1021\/acs.jcim.5b00559","volume":"55","author":"T Sterling","year":"2015","unstructured":"Sterling, T. & Irwin, J. J. ZINC 15\u2014ligand discovery for everyone. J. Chem. Inf. Modeling 55, 2324\u20132337 (2015).","journal-title":"J. Chem. Inf. Modeling"},{"key":"58496_CR38","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/S0022-2836(95)80037-9","volume":"245","author":"G Jones","year":"1995","unstructured":"Jones, G., Willett, P. & Glen, R. C. Molecular recognition of receptor sites using a genetic algorithm with a description of desolvation. J. Mol. Biol. 245, 43\u201353 (1995).","journal-title":"J. Mol. Biol."},{"key":"58496_CR39","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1007\/978-1-62703-050-2_15","volume":"929","author":"S Kortagere","year":"2012","unstructured":"Kortagere, S., Krasowski, M. D. & Ekins, S. Ligand-and structure-based pregnane S receptor models. Methods Mol. Biol. 929, 359\u2013375 (2012).","journal-title":"Methods Mol. Biol."},{"key":"58496_CR40","doi-asserted-by":"crossref","unstructured":"Lill, M. In In Silico Models for Drug Discovery (ed. Kortagere, S.) 1\u201312 (Humana Press, 2013).","DOI":"10.1007\/978-1-62703-342-8_1"},{"key":"58496_CR41","doi-asserted-by":"publisher","first-page":"10875","DOI":"10.1523\/JNEUROSCI.0164-08.2008","volume":"28","author":"C Miech","year":"2008","unstructured":"Miech, C., Pauer, H. U., He, S. & Schwarz, T. L. Presynaptic local signaling by a canonical wingless pathway regulates development of the Drosophila neuromuscular junction. J. Neurosci. 28, 10875\u201310884 (2008).","journal-title":"J. Neurosci."},{"key":"58496_CR42","doi-asserted-by":"publisher","first-page":"1176777","DOI":"10.3389\/fnbeh.2023.1176777","volume":"17","author":"A Bhatnagar","year":"2023","unstructured":"Bhatnagar, A. et al. Novel EAAT2 activators improve motor and cognitive impairment in a transgenic model of Huntington\u2019s disease. Front. Behav. Neurosci. 17, 1176777 (2023).","journal-title":"Front. Behav. Neurosci."},{"key":"58496_CR43","unstructured":"Rudrapal, M. & Egbuna, C. Computer Aided Drug Design (CADD): From Ligand-Based Methods to Structure-Based Approaches (Elsevier, 2022)."},{"key":"58496_CR44","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1016\/j.jmgm.2008.04.001","volume":"2","author":"S Kortagere","year":"2008","unstructured":"Kortagere, S., Ekins, S. & Welsh, W. J. Halogenated ligands and their interactions with amino acids: implications for structure-activity and structure-toxicity relationships. J. Mol. Graph Modeling 2, 170\u2013177 (2008).","journal-title":"J. Mol. Graph Modeling"},{"key":"58496_CR45","doi-asserted-by":"publisher","first-page":"15564","DOI":"10.1073\/pnas.0804249105","volume":"105","author":"EA Thomas","year":"2008","unstructured":"Thomas, E. A. et al. The HDAC inhibitor 4b ameliorates the disease phenotype and transcriptional abnormalities in Huntington\u2019s disease transgenic mice. Proc. Natl. Acad. Sci. USA 105, 15564\u201315569 (2008).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"58496_CR46","doi-asserted-by":"publisher","DOI":"10.1002\/alz.069366","volume":"18","author":"C Wang","year":"2022","unstructured":"Wang, C. & Zhang, C. Novel HDAC11 inhibitors for Alzheimer\u2019s disease treatment in preclinical models. Alzheimer\u2019s. Dement. 18, e069366 (2022).","journal-title":"Alzheimer\u2019s. Dement."},{"key":"58496_CR47","doi-asserted-by":"publisher","first-page":"E11148","DOI":"10.1073\/pnas.1805436115","volume":"115","author":"KJ Janczura","year":"2018","unstructured":"Janczura, K. J. et al. Inhibition of HDAC3 reverses Alzheimer\u2019s disease-related pathologies in vitro and in the 3xTg-AD mouse model. Proc. Natl. Acad. Sci. USA 115, E11148\u2013E11157 (2018).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"58496_CR48","unstructured":"NCT03056495. Clinical Trial to Determine Tolerable Dosis of Vorinostat in Patients With Mild Alzheimer Disease, 2017. https:\/\/clinicaltrials.gov\/ct2\/show\/NCT03056495."},{"key":"58496_CR49","unstructured":"NCT03061474. Nicotinamide as an Early Alzheimer\u2019s Disease Treatment (NEAT), 2017. https:\/\/clinicaltrials.gov\/ct2\/show\/NCT03061474."},{"key":"58496_CR50","doi-asserted-by":"publisher","first-page":"4283","DOI":"10.3390\/ijms20174283","volume":"20","author":"H Jeong","year":"2019","unstructured":"Jeong, H. et al. Pan-HDAC inhibitors promote Tau aggregation by increasing the level of acetylated Tau. Int. J. Mol. Sci. 20, 4283 (2019).","journal-title":"Int. J. Mol. Sci."},{"key":"58496_CR51","doi-asserted-by":"publisher","first-page":"e69964","DOI":"10.1371\/journal.pone.0069964","volume":"8","author":"JE Hanson","year":"2013","unstructured":"Hanson, J. E. et al. SAHA enhances synaptic function and plasticity in vitro but has limited brain availability in vivo and does not impact cognition. PLoS ONE 8, e69964 (2013).","journal-title":"PLoS ONE"},{"key":"58496_CR52","unstructured":"Cognitive-vitality-report. Vorinostat (Zolinza). Alzheimer\u2019s Drug Discovery Foundation https:\/\/www.alzdiscovery.org (2018)."},{"key":"58496_CR53","doi-asserted-by":"publisher","DOI":"10.23937\/2469-5858\/1510021","volume":"3","author":"M Phelan","year":"2017","unstructured":"Phelan, M., Mulnard, R., Gillen, D. & Schreiber, S. Phase II clinical trial of nicotinamide for the treatment of mild to moderate Alzheimer\u2019s disease. J. Geriatr. Med. Gerontol. 3, e21 (2017).","journal-title":"J. Geriatr. Med. Gerontol."},{"key":"58496_CR54","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1111\/jnc.14599","volume":"148","author":"IF Harrison","year":"2019","unstructured":"Harrison, I. F., Powell, N. M. & Dexter, D. T. The histone deacetylase inhibitor nicotinamide exacerbates neurodegeneration in the lactacystin rat model of Parkinson\u2019s disease. J. Neurochem. 148, 136\u2013156 (2019).","journal-title":"J. Neurochem."},{"key":"58496_CR55","first-page":"364","volume":"47","author":"B Devipriya","year":"2010","unstructured":"Devipriya, B., Parameswari, A. R., Rajalakshmi, G., Palvannan, T. & Kumaradhas, P. Exploring the binding affinities of p300 enzyme activators CTPB and CTB using docking method. Indian J. Biochem Biophys. 47, 364\u2013369 (2010).","journal-title":"Indian J. Biochem Biophys."},{"key":"58496_CR56","doi-asserted-by":"publisher","first-page":"682","DOI":"10.1016\/j.sbi.2008.11.004","volume":"18","author":"CaD Berndsen","year":"2013","unstructured":"Berndsen, Ca. D. JM. Catalysis and Substrate selection by histone\/protein lysine acetyltransferase. Curr. Opin. Struct. Biol. 18, 682\u2013689 (2013).","journal-title":"Curr. Opin. Struct. Biol."},{"key":"58496_CR57","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1016\/S1097-2765(00)80452-9","volume":"5","author":"OD Lau","year":"2000","unstructured":"Lau, O. D. et al. HATs off: selective synthetic inhibitors of the histone acetyltransferases p300 and PCAF. Mol. Cell 5, 589\u2013595 (2000).","journal-title":"Mol. Cell"},{"key":"58496_CR58","doi-asserted-by":"publisher","first-page":"4935","DOI":"10.7150\/thno.73223","volume":"12","author":"Q Chen","year":"2022","unstructured":"Chen, Q. et al. Histone acetylatransferases CBP\/p300 in tumorigenesis and CBP\/p300 inhibitors as promising novel anticancer agents. Theranostics 12, 4935\u20134948 (2022).","journal-title":"Theranostics"},{"key":"58496_CR59","doi-asserted-by":"publisher","first-page":"1618","DOI":"10.1038\/s41593-018-0253-7","volume":"21","author":"S Marzi","year":"2018","unstructured":"Marzi, S. et al. A histone acetylome-wide association study of Alzheimer\u2019s disease identifies disease-associated H3K27ac differences in the entorhinal cortex. Nat. Neurosci. 21, 1618\u20131627 (2018).","journal-title":"Nat. Neurosci."},{"key":"58496_CR60","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1038\/s41593-018-0101-9","volume":"21","author":"R Natvio","year":"2018","unstructured":"Natvio, R. et al. Dysregulation of the epigenetic landscape of normal aging in Alzheimer\u2019s disease. Nat. Neurosci. 21, 497\u2013505 (2018).","journal-title":"Nat. Neurosci."},{"key":"58496_CR61","doi-asserted-by":"publisher","first-page":"e99467","DOI":"10.1371\/journal.pone.0099467","volume":"9","author":"A Hendrickx","year":"2014","unstructured":"Hendrickx, A. et al. Epigenetic regulations of immediate early genes experssion involved in memory formation by the amyloid precursor protein of Alzheimer disease. PLoS ONE 9, e99467 (2014).","journal-title":"PLoS ONE"},{"key":"58496_CR62","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1046\/j.1365-2443.1998.00229.x","volume":"3","author":"A Kimura","year":"1998","unstructured":"Kimura, A. & Horikoshi, M. Tip60 acetylates six lysines of a specific class in core histones in vitro. Genes Cells 3, 789\u2013800 (1998).","journal-title":"Genes Cells"},{"key":"58496_CR63","doi-asserted-by":"publisher","first-page":"2398","DOI":"10.1523\/JNEUROSCI.2331-22.2023","volume":"43","author":"A Bhatnagar","year":"2023","unstructured":"Bhatnagar, A. et al. Tip60\u2019s novel RNA-binding function modulates alternative splicing of pre-mRNA targets implicated in Alzheimer\u2019s disease. J. Neurosci. 43, 2398\u20132423 (2023).","journal-title":"J. Neurosci."},{"key":"58496_CR64","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1002\/prot.10465","volume":"52","author":"ML Verdonk","year":"2003","unstructured":"Verdonk, M. L., Cole, J. C., Hartshorn, M. J., Murray, C. W. & Taylor, R. D. Improved protein\u2013ligand docking using GOLD. Proteins: Struct. Funct. Bioinforma. 52, 609\u2013623 (2003).","journal-title":"Proteins: Struct. Funct. Bioinforma."},{"key":"58496_CR65","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1201\/9781420028775.ch15","volume":"1","author":"J Cole","year":"2005","unstructured":"Cole, J., Nissink, J. & Taylor, R. Protein-ligand docking and virtual screening with GOLD. Virtual Screen. Drug Discov. 1, 379\u2013415 (2005).","journal-title":"Virtual Screen. Drug Discov."},{"key":"58496_CR66","unstructured":"The PyMOL Molecular Graphics System, 2015. Version 2.0 Schr\u00f6dinger, LLC."},{"key":"58496_CR67","doi-asserted-by":"publisher","first-page":"1986","DOI":"10.1021\/jm991174y","volume":"43","author":"\u00c5 Frostell-Karlsson","year":"2000","unstructured":"Frostell-Karlsson, \u00c5. et al. Biosensor analysis of the interaction between immobilized human serum albumin and drug compounds for prediction of human serum albumin binding levels. J. Med. Chem. 43, 1986\u20131992 (2000).","journal-title":"J. Med. Chem."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-58496-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-58496-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-58496-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,9]],"date-time":"2025-04-09T13:25:34Z","timestamp":1744205134000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-025-58496-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,9]]},"references-count":67,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["58496"],"URL":"https:\/\/doi.org\/10.1038\/s41467-025-58496-w","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,9]]},"assertion":[{"value":"15 July 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Compounds C1\u2013C10 and P1\u2013P13 described in this manuscript are listed in the U. S. Patent Application No. 18\/891,352, filed September 20, 2024; S.K., A.B., and F.E. are named inventors on the patent. The remaining authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"3347"}}